Progress of Digestive Endoscopy
Online ISSN : 2187-4999
Print ISSN : 1348-9844
ISSN-L : 1348-9844
Clinical study
The usefulness of l-menthol as an antispasmodic drug during ERCP
Masatoshi Mabuchi, Takako Adachi, Takeshi Onda, Hanae Kajiyama, Kotaro Matsumoto, Katsunori Sekine, Takayuki Tsujikawa, Noritaka Ozawa, Yusuke Kajiyama, Shinpei Doi, Koichiro Sato, Kentaro Kikuchi, Ichiro Yasuda
Author information
Keywords: ERCP, l-menthol
JOURNAL FREE ACCESS

2016 Volume 89 Issue 1 Pages 70-71

Details
Abstract

Background : A risk factor during endoscopic retrograde cholangiopancreatography (ERCP) is peristalsis of the duodenum. Common antispasmodic drugs such as scopolamine butylbromide and glucagon are associated with a risk of complications in patients with heart, prostate, diabetes mellitus, and thyroid disease. l-menthol has an antispasmodic effect on the smooth muscles of the stomach, bowel, and colon.
Methods : We prospectively evaluated ERCP without gastrectomy at Teikyo University Mizonokuchi Hospital, between July 2014 and March 2016.
Results : The total number of eligible patients was 359. The complete procedure rate with l-menthol alone was 90.5%. The median total procedure time was 23 seconds. In almost 80% of cases, appropriate peristalsis of duodenum for ERCP l-menthol alone was observed.
Conclusion : We propose that l-menthol can be useful as an antispasmodic drug during ERCP.

Content from these authors
© 2016 Japan Gastroenterological Endoscopy Society Kanto Chapter
Previous article Next article
feedback
Top